Results 11 to 20 of about 39,211 (299)

6th Golden Helix Pharmacogenomics Day: pharmacogenomics and individualized therapy [PDF]

Human Genomics, 2012
The Golden Helix Pharmacogenomics Days are international scientific meetings aiming to educate healthcare professionals and biomedical scientists about pharmacogenomics and personalized medicine.
Stojiljkovic Maja, Fazlagic Amira, Dokmanovic-Krivokapic Lidija, Nikcevic Gordana, Patrinos George P, Pavlovic Sonja, Zukic Branka   +6 more
doaj   +3 more sources

Pharmacogenomics In Pharmacy Practice: Current Perspectives [PDF]

Integrated Pharmacy Research and Practice, 2019
Hazem Elewa, Ahmed Awaisu College of Pharmacy, Qatar University Health, Qatar University, Doha, QatarCorrespondence: Hazem ElewaCollege of Pharmacy, Qatar University Health, Qatar University, P.O.
Elewa H, Awaisu A
doaj   +2 more sources

Cancer pharmacogenomics, challenges in implementation, and patient-focused perspectives

Pharmacogenomics and Personalized Medicine, 2016
Jai N Patel Department of Cancer Pharmacology, Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA Abstract: Cancer pharmacogenomics is an evolving landscape and has the potential to significantly impact cancer care and precision ...
Patel JN
doaj   +1 more source

Pharmacogenomics and Morphine [PDF]

The Journal of Clinical Pharmacology, 2021
AbstractMorphine is an opioid analgesic indicated in the treatment of acute and chronic moderate to severe pain. From a pharmacodynamic standpoint, morphine exerts its effects by agonizing mu‐opioid receptors predominantly, resulting in analgesia and sedation.
Adaku Ofoegbu, Earl B. Ettienne
openaire   +2 more sources

Pharmacogenomics of Antibiotics [PDF]

International Journal of Molecular Sciences, 2020
Although the introduction of antibiotics in medicine has resulted in one of the most successful events and in a major breakthrough to reduce morbidity and mortality caused by infectious disease, response to these agents is not always predictable, leading to differences in their efficacy, and sometimes to the occurrence of adverse effects.
Stocco G., Lucafo M., Decorti G.
openaire   +4 more sources

British South Asian ancestry participants views of pharmacogenomics clinical implementation and research: a thematic analysis. [PDF]

, 2023
BACKGROUND: South Asian ancestry populations are underrepresented in genomic studies and therapeutics trials. British South Asians suffer from multi-morbidity leading to polypharmacy.
Islam, MR, Magavern, EF, Genes & Health Research Team, Caulfield, MJ, Clinch, M, Raza, M, Lerner, R, Durrani, F   +7 more
core   +1 more source

Conference scene : Golden Helix Pharmacogenomics Days : educational activities on pharmacogenomics and personalized medicine [PDF]

, 2012
The Golden Helix Pharmacogenomics Days are high-profile international educational scientific meetings discussing pharmacogenomics and personalized medicine.
Borg, Joseph J., Squassina, Alessio, Patrinos, George P., Severino, Giovanni, Grech, Godfrey, Fenech, Anthony G.   +5 more
core   +2 more sources

The Sixth European Society of Pharmacogenomics and Personalised Therapy Congress

, 2023
On 8-9 November 2022, the European Society of Pharmacogenomics and Personalised Therapy organized its sixth biennial congress, in Belgrade, Serbia (congress website: www.sspt.rs).
Morris, Tiffany, Swen, Jesse J, Christrup, Lona, Zukic, Branka, Patrinos, George P., Van Den Broek, Wout, Bozina, Nada, Llerena, Adrian, Manolopoulos, Vangelis G., Ansari, Marc, Niemi, Mikko, Sipeky, Cilla, Daly, Ann K, van Schaik, Ron Hn, Swen, Jesse J., Molden, Espen, Florindi, Francesco, Pavlovic, Sonja, Patrinos, George P, Manolopoulos, Vangelis G, Stankovic, Sanja, Akin, Demet, Henricks, Linda M, Henricks, Linda M., Primorac, Dragan, Müller, Daniel, Daly, Ann K., Ansari Djaberi, Marc Georges, Russmann, Stefan, Ingelman-Sundberg, Magnus, Van Schaik, Ron H.N., Niemi, M, Swen, Jesse Joachim, Primorac, D, Daly, AK, Swen, JJ, Ingelman-Sundberg, M,, Zukic, B, van, Schaik RHN, Manolopoulos, VG, Patrinos, GP, Morris, T   +41 more
core   +1 more source

Pharmacogenomics

The Lancet, 2019
Genomic medicine, which uses DNA variation to individualise and improve human health, is the subject of this Series of papers. The idea that genetic variation can be used to individualise drug therapy-the topic addressed here-is often viewed as within reach for genomic medicine. We have reviewed general mechanisms underlying variability in drug action,
Dan M, Roden, Howard L, McLeod, Mary V, Relling, Marc S, Williams, George A, Mensah, Josh F, Peterson, Sara L, Van Driest   +6 more
openaire   +3 more sources

Platelet pharmacogenomics [PDF]

Journal of Thrombosis and Haemostasis, 2010
Platelet responsiveness to conventional antiplatelet therapy underlies a high interindividual variability influenced by various factors. For instance, antiplatelet therapy does not curtail the expected effects in a relevant number of patients as demonstrated by the occurrence of repeated cardiovascular events including stent thrombosis and/or by ...
C S, Zuern, M, Schwab, M, Gawaz, T, Geisler   +3 more
openaire   +2 more sources